Historical record - last NADAC effective date: 8/18/2021
This NDC is on FDA's drug shortage list (posted Jun 6, 2018)
Reported reason: Other
Product Information
KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.8975 per ML under NDC 00641604325. Its NADAC has been published 111 times since Dec 12, 2018.
FDA first approved this application on Jul 21, 2004. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641604325
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
8/18/2021
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA075772FDA Approved
7/21/2004
TE Code
AP
On Market Since
7/21/2004
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 111 times since Dec 12, 2018, and over the history we have for it it has declined 28.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8975 per ML |
|---|---|
| All-time high | $1.2624 (Jun 12, 2019) |
| All-time low | $0.7764 (May 19, 2021) |
| Median price | $1.0367 |
| Average price | $1.0490 |
| Largest weekly change | -19.1% (May 19, 2021) |
| Weeks tracked | 111 |
| Tracking since | Dec 12, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
-28.9%
Last surveyed Aug 25, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.8975 per ML (NDC 00641604325), effective Aug 25, 2021.
How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 28.9%. It has been tracked across 111 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?
Since Dec 12, 2018, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.7764 (May 19, 2021) to a high of $1.2624 (Jun 12, 2019), with a median of $1.0367 per ML.
Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.4980 per ML — about 45% below KETOROLAC 60 MG/2 ML VIAL.
Who manufactures KETOROLAC 60 MG/2 ML VIAL?
KETOROLAC 60 MG/2 ML VIAL (NDC 00641604325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is KETOROLAC 60 MG/2 ML VIAL in shortage?
Yes — NDC 00641604325 is currently listed in FDA's drug shortage database (posted Jun 6, 2018). Reported reason: Other.